Keywords: سیناکالکت; Capillary electrophoresis; Chiral separation; Cinacalcet; Impurities; Method operable design region; Quality by Design;
مقالات ISI سیناکالکت (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سیناکالکت; Cinacalcet; Dialysis; Propensity score; Registry; Secondary hyperparathyroidism; Survival;
Keywords: سیناکالکت; Cinacalcet; Chronic kidney disease; Secondary hyperparathyroidism; Parathyroid hormone; Calcium; Phosphorus; Bone turnover markersCinacalcet; Enfermedad renal crónica; Hiperparatiroidismo secundario; Hormona paratiroidea; Calcio; Fósforo; Marcadores de re
Keywords: سیناکالکت; Chronic kidney disease; mineral and bone disorder (MBD); calcium; cinacalcet; daily dialysis; end stage renal disease (ESRD); Frequent Hemodialysis Network; home dialysis; intensive hemodialysis; nocturnal hemodialysis; parathyroid hormone; phosphate bind
Keywords: سیناکالکت; Cardiac fibrosis; Uremia; Cinacalcet; Parathyroid hormone; Endothelial-to-mesenchymal transition;
Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism
Keywords: سیناکالکت; Evocalcet; Calcium-sensing receptor (CaSR); Allosteric calcium-sensing receptor agonist; Hyperparathyroidism; Cinacalcet;
Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial
Keywords: سیناکالکت; calcimimetic; cinacalcet; hemodialysis; hypocalcemia; parathyroid hormone; secondary hyperparathyroidism;
Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism
Keywords: سیناکالکت; cinacalcet; evocalcet; gastrointestinal; Japan; randomized controlled trial; secondary hyperparathyroidism;
Activation of calcium-sensing receptor by allosteric agonists cinacalcet and AC-265347 abolishes the 1,25(OH)2D3-induced Ca2+ transport: Evidence that explains how the intestine prevents excessive Ca2+ absorption
Keywords: سیناکالکت; Calcium absorption; Calcium-sensing receptor (CaSR); Cinacalcet; Fibroblast growth factor-23 (FGF-23); Lactation; Vitamin D;
Hypercalcaemia and primary hyperparathyroidism
Keywords: سیناکالکت; Cinacalcet; hypercalcaemia; MRCP; parathyroidectomy; primary hyperparathyroidism; vitamin D;
Parathyroid hormone contributes to the down-regulation of cytochrome P450 3A through the cAMP/PI3K/PKC/PKA/NF-κB signaling pathway in secondary hyperparathyroidism
Keywords: سیناکالکت; Chronic kidney disease; Cytochrome P450 3A; Cinacalcet; Parathyroid hormone; Secondary hyperparathyroidism;
Development and validation of a quantitative assay for the determination of cinacalcet and its main metabolites in human plasma using RP-HPLC method
Keywords: سیناکالکت; Cinacalcet; Metabolites; Derivation; Plasma; RP-HPLC; Validation;
The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial
Keywords: سیناکالکت; Win ratio; Composite endpoints; EVOLVE trial; Cinacalcet;
Separation and quantitative determination of cinacalcet metabolites in urine sample using RP-HPLC after derivation with a fluorescent labeling reagent
Keywords: سیناکالکت; Cinacalcet; Metabolites; Fluorescent labeling; Urine; RP-HPLC; Validation
Pharmacokinetic and Pharmacodynamic Properties of Cinacalcet (KRN1493) in Chinese Healthy Volunteers: A Randomized, Open-label, Single Ascending-dose and Multiple-dose, Parallel-group Study
Keywords: سیناکالکت; Chinese healthy volunteers; cinacalcet; pharmacodynamic properties; pharmacokinetic properties; secondary hyperparathyroidism;
A two-step, one pot preparation of amines via acyl succinimides. Synthesis of the calcimimetic agents cinacalcet, NPS R-467, and NPS R-568
Keywords: سیناکالکت; Succinimide; Cinacalcet; NPS R-467; NPS R-568; Acyl succinimide; Reductive amination;
Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial
Keywords: سیناکالکت; cinacalcet; cost-effectiveness; dialysis; hyperparathyroidism;
Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism
Keywords: سیناکالکت; Secondary hyperparathyroidism; Renal transplantation; Paricalcitol; Cinacalcet; CalcitriolHiperparatiroidismo secundario; Trasplante renal; Paricalcitol; Cinacalcet; Calcitriol
Efecto de paricalcitol sobre el metabolismo mineralóseo en pacientes trasplantados renales con hiperparatiroidismo secundario
Keywords: سیناکالکت; Hiperparatiroidismo secundario; Trasplante renal; Paricalcitol; Cinacalcet; CalcitriolSecondary hyperparathyroidism; Renal transplantation; Paricalcitol; Cinacalcet; Calcitriol
Medical Management of Primary Hyperparathyroidism
Keywords: سیناکالکت; Bisphosphonates; cinacalcet; estrogen; medical management; primary hyperparathyroidism; raloxifene;
Hypercalcaemia and primary hyperparathyroidism
Keywords: سیناکالکت; cinacalcet; hypercalcaemia; parathyroidectomy; primary hyperparathyroidism; vitamin D
Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan
Keywords: سیناکالکت; cinacalcet; dialysis patients; mineral and bone disorder;
Hiperparatiroidismo autónomo en paciente renal crónico estadio 3: valoración clÃnica a propósito de un caso
Keywords: سیناکالکت; Hiperparatiroidismo; Cinacalcet; Calcimimético; Hyperparathyroidism; Cinacalcet; Calcimimetic;
Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders
Keywords: سیناکالکت; calcium-sensing receptor; calcimimetic; calcilytic; hyperparathyroidism; osteoporosis; cinacalcet; hypophosphatemia; hypercalcemia
Efecto de cinacalcet sobre la hormona paratiroidea en el hiperparatiroidismo hipercalcémico del trasplantado renal
Keywords: سیناکالکت; Cinacalcet; Hormona paratiroidea; Hiperparatiroidismo; Trasplante renal; Biomarcadores óseos; Cinacalcet; Parathyroid hormone; Hyperparathyroidism; Renal transplantation; Bone biomarkers;
L’étude ADVANCE en questions
Keywords: سیناکالکت; Hyperparathyroïdie; Calcimimétique; Calcifications vasculaires; Vitamine DHyperparathyroidism; Cinacalcet; Vitamin D; Vascular calcification
Evaluación retrospectiva de la efectividad y seguridad de cinacalcet para el tratamiento de hiperparatiroidismo secundario dependiendo del valor basal de paratohormona intacta
Keywords: سیناکالکت; Cinacalcet; Hiperparatirodismo secundario; Diálisis; Cinacalcet; Secondary hyperparathyroidism; Dialysis;
Potentialisation des effets de l’hyperkaliémie par une hypocalcémie induite par le cinacalcet en dialyse
Keywords: سیناکالکت; Hyperkaliémie; Hypocalcémie; CinacalcetHyperkalemia; Hypocalcemia; Cinacalcet
Efficacité du cinacalcet en pratique clinique chez les patients dialysés présentant une hyperparathyroïdie secondaire : observatoire ECHO – Expérience française
Keywords: سیناکالکت; Calcimimétiques; Cinacalcet; Pratique clinique; Hyperparathyroïdisme secondaire; DialyseCalcimimetics; Cinacalcet; Clinical practice; Secondary hyperparathyroidism; Dialysis
Effet du cinacalcet sur l’homéostasie calcique et le remodelage osseux chez 13 transplantés rénaux présentant une hyperparathyroïdie avec hypercalcémie
Keywords: سیناکالکت; Cinacalcet; Hypercalcémie; Hypercalciurie; Hyperparathyroïdie; Transplantation rénale; Remodelage osseuxCinacalcet; Hypercalcaemia; Hypercalciuria; Hyperparathyroidism; Post-renal transplantation; Bone remodeling
Efecto del seguimiento farmacoterapéutico en pacientes con hiperparatiroidismo secundario tratados con cinacalcet
Keywords: سیناکالکت; Atención farmacéutica; Cinacalcet; Hiperparatiroidismo secundario; Problemas relacionados con medicamentos; Seguimiento farmacoterapéutico; Servicios farmacéuticos; Cinacalcet; Drug-related problems; Pharmaceutical care; Pharmacotherapeutic follow-up;
Pharmacokinetic and Pharmacodynamic Properties of the Calcimimetic Agent Cinacalcet (KRN1493) in Healthy Male Korean Subjects: A Randomized, Open-Label, Single Ascending–Dose, Parallel-Group Study
Keywords: سیناکالکت; cinacalcet; Korean; pharmacodynamics; pharmacokinetics; secondary hyperparathyroidism
Outpatient Management of Primary Hyperparathyroidism
Keywords: سیناکالکت; Cinacalcet; Intact parathyroid hormone; Minimally invasive surgery; Primary hyperparathyroidism
Hyperparathyroïdie secondaire et anémie. Effets d'un calcimimétique sur le contrôle de l'anémie des hémodialysés chroniques. Ãtude pilote
Keywords: سیناکالکت; Agents stimulants l'érythropoïèse; anémie; Calcimimétique; Cinacalcet; Hyperparathyroïdie secondaire; index de résistance à l'érythropoïétine; Anemia; Calcimimetic; cinacalcet; Erythropoietin resistance index; erythropoiesis stimulating age
Dosis bajas de cinacalcet reducen el calcio sérico en pacientes con hiperparatiroidismo primario no subsidiario de tratamiento quirúrgico
Keywords: سیناکالکت; Cinacalcet; Calciomiméticos; Hiperparatiroidismo primarioCinacalcet; Calcium mimetics; Primary hyperparathyroidism
Quantification of cinacalcet by LC–MS/MS using liquid–liquid extraction from 50 μL of plasma
Keywords: سیناکالکت; Cinacalcet; Liquid chromatography–tandem mass spectrometry; Plasma; Clinical trials
Pivotal Role of Paricalcitol in the Treatment of Calcific Uremic Arteriolopathy in the Presence of a Parathyroid Adenoma
Keywords: سیناکالکت; Calcific uremic arteriolopathy; cinacalcet; paricalcitol; parathyroid adenoma;
Discovery of a class of calcium sensing receptor positive allosteric modulators; 1-(benzothiazol-2-yl)-1-phenylethanols
Keywords: سیناکالکت; SAR; GPCR; CaSR; PAM; Allosteric; Modulators; Structure-activity relationship; Calciumsensing receptor; Cinacalcet; Calindol; Hyperparathyroidism; Fendiline; In vivo; Parathyroid hormone; 1-(benzothiazol-2-yl)-1-phenylethanols;
Traitement de l’hyperparathyroïdie secondaire, résistante aux thérapeutiques conventionnelles, et de l’hyperparathyroïdie tertiaire par le cinacalcet : une stratégie efficace
Keywords: سیناکالکت; Hyperparathyroïdie; Calcimimétique; Vitamine D; Métabolisme minéral et osseux; HémodialyseHyperparathyroidism; Cinacalcet; Vitamin D; Mineral metabolism; Haemodialysis
Management of Skeletal Health in Patients With Asymptomatic Primary Hyperparathyroidism
Keywords: سیناکالکت; Bisphosphonate; cinacalcet; DXA; fracture; osteoporosis; parathyroidectomy; risk; treatment;
Calcific Uremic Arteriolopathy: Contemporary Pharmacotherapy
Keywords: سیناکالکت; Calcific uremic arteriolopathy; Calciphylaxis; Bisphosphonates; Cinacalcet; Sodium thiosulfate;
Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients
Keywords: سیناکالکت; cinacalcet; hemodialysis; outcomes; secondary hyperparathyroidism; survival
Hiperparatiroidismo primario. Una alternativa a la cirugÃa
Keywords: سیناکالکت; Cinacalcet; Ácido zeledrónico; Hipercalcemia; Hiperparatiroidismo; Calcimiméticos; Cinacalcet; Zoledronic acid; Hypercalcemia; Hyperparathyroidism; Calcimimetic;
Le traitement de la calciphylaxie par cinacalcet : une alternative médicale à la parathyroïdectomie
Keywords: سیناکالکت; Calciphylaxie; Nécrose; Cinacalcet; DialyseCalciphylaxis; Necrosis; Cinacalcet; Dialysis
Hypercalcaemia and primary hyperparathyroidism
Keywords: سیناکالکت; cinacalcet; conservative management; hypercalcaemia; primary hyperparathyroidism; parathyroidectomy
Cinacalcet-Induced Leukocytoclastic Vasculitis
Keywords: سیناکالکت; Cinacalcet; leukocytoclastic vasculitis; palpable purpura; secondary hyperparathyroidism;
Acute and One-Year Effects of Cinacalcet in Patients With Persistent Primary Hyperparathyroidism After Unsuccessful Parathyroidectomy
Keywords: سیناکالکت; Cinacalcet; Primary hyperparathyroidism; Parathyroidectomy;
Cinacalcet and the Prevention of Secondary Hyperparathyroidism in Rats With Aldosteronism
Keywords: سیناکالکت; Aldosteronism; Calcium overloading; Secondary hyperparathyroidism; Oxidative stress; Cinacalcet;
Cinacalcet suppresses calcification of the aorta and heart in uremic rats
Keywords: سیناکالکت; calcification; calcium; calcium receptor; cinacalcet; parathyroid hormone; phosphorus
The role of calcimimetics in chronic kidney disease
Keywords: سیناکالکت; secondary hyperparathyroidism; vitamin D; cinacalcet; calcium sensing receptor;